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Abstract Nuclear receptors function as ligand-dependent tran-
scription factors by recruiting cofactors that remodel chromatin
and recruit the transcription machinery. RIP140 (receptor in-
teracting protein with a molecular weight of 140 kDa) is a
widely expressed corepressor that has the potential to inhibit
the transcriptional activity of most, if not all nuclear receptors.
Mice devoid of RIP140 indicate that it plays a crucial role in
female fertility and in adipose biology. It is essential in the
ovary for ovulation, speci¢cally oocyte release but not luteinisa-
tion of mature follicles. Our goal is to identify the key nuclear
receptor(s) and their target genes responsible for ovulation.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Nuclear receptors comprise a superfamily of ligand-depen-
dent transcription factors that range from 21 members in
Drosophila, 48 members in mouse and human to greater
than 250 in Caenorhabditis elegans. Their function as tran-
scriptional activators or repressors depends on the recruitment
of cofactors to target genes where they play distinct roles.
Gene activation depends on remodelling chromatin to allow
the subsequent recruitment of transcription machinery. This
process can be reversed to repress gene transcription tran-
siently or ultimately to silence genes completely when they
are packaged into heterochromatin. These alterations are
achieved by the recruitment of coactivators and corepressors
that reorganise chromatin templates for the recruitment of
basal transcription factors and RNA polymerase II.
Two distinct types of chromatin remodelling activities have
been well characterised. Firstly, there are enzymes that cata-
lyse modi¢cations of histones that make up the nucleosome
core particle, including acetylation [1], methylation [2^4] and
phosphorylation [5]. These modi¢cations result in a change in
the association of a nucleosome with DNA. For example,
histone acetyltransferases (HATs), which acetylate lysine res-
idues in the N-terminal tail of histones are proposed to unfold
chromatin structure, thereby facilitating the binding of tran-
scriptional regulators to promoters [1]. The second class of
enzymes consists of adenosine triphosphate (ATP)-dependent
chromatin remodelling complexes [6,16], which use the energy
of ATP hydrolysis to locally disrupt the association of his-
tones with DNA.
The process of transcriptional activation can be reversed by
the recruitment of corepressors, including enzymes such as
histone deacetylases (HDACs) or phosphatases, which remove
the histone modi¢cation. Presumably chromatin remodelling
activities are recruited to target promoters in a highly regu-
lated manner by mechanisms involving complex protein^pro-
tein interactions but these have yet to be fully elucidated.
Biochemical and genetic studies have identi¢ed a large num-
ber of receptor interacting proteins but whether they are all
bona ¢de coactivators or corepressors remains to be estab-
lished.
We exploited a far-Western blotting procedure to identify
proteins that could interact with the ligand binding domain of
the oestrogen receptor in the presence of oestrogen (Fig. 1).
This analysis led to the discovery of two families of receptor
interacting proteins with molecular weights of 140 and 160
kDa, RIP140 and RIP160, that were subsequently found to
interact with most if not all nuclear receptors in a ligand-de-
pendent manner [7,15]. This review will focus on the function
of RIP140.
2. Properties of the RIP140 corepressor
RIP140 is a nuclear protein of 128 kDa encoded by a single
gene on chromosome 21 that is highly conserved in verte-
brates (Fig. 2). Binding to nuclear receptors in a ligand-de-
pendent manner is mediated by 10 LXXLL (peptide sequence
where L is leucine and X is any amino acid) or LXXLL-like
motifs [8] found in many cofactors including the RIP160/p160
family of coactivators. A so-called ‘charge clamp’ found on
the surface of the ligand binding domain of receptors induces
the motif to form a helical structure that docks into a groove
formed within the activation domain of the receptor called
activation function 2 (AF2) [9]. Upon binding, RIP140 inhib-
0014-5793 / 03 / $22.00 H 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
doi:10.1016/S0014-5793(03)00564-7
*Corresponding author. Fax: (44)-20-7594 2184.
E-mail address: m.parker@imperial.ac.uk (M. Parker).
Abbreviations: RIP140, receptor interacting protein with a molecular
weight of 140 kDa; HDACs, histone deacetylases; LXXLL, peptide
sequence where L is leucine and X is any amino acid; CtBP, carboxy-
terminal binding protein; LH, luteinising hormone; p.c., post-coitum;
COX-2, cyclooxygenase 2
FEBS 27351 12-6-03 Cyaan Magenta Geel Zwart
FEBS 27351 FEBS Letters 546 (2003) 149^153
its the transcriptional activity of nuclear receptors and func-
tions as a corepressor. Transcriptional repression seems to
depend on the recruitment of HDACs [10] and/or carboxy-
terminal binding protein (CtBP) [11]. CtBP was identi¢ed by
its interaction with adenoviral E1a repressor and shown to
interact with a so-called PXDLS motif which is also found
in RIP140. Recent work in our laboratory con¢rms the pres-
ence of these two binding sites in RIP140 but further suggests
that there are additional repression domains at the C-terminus
of the protein. Thus RIP140, in common with the RIP160/
p160 coactivators, seems to function primarily as a platform
for the recruitment of additional proteins and enzymes re-
quired for chromatin remodelling.
3. Biological role of RIP140
The role of RIP140 has been investigated by generating
mice devoid of the gene [12]. Replacement of the RIP140
coding sequence with that of lac Z enabled us to monitor
L-galactosidase activity produced under the control of the
RIP140 promoter as an indication of the cellular distribution
of RIP140 expression. A survey of tissues indicates that it is
Fig. 1. Far-Western blotting to identify oestrogen receptor interacting proteins. Nuclear extracts were prepared from ZR-75 breast cancer cells,
separated by sodium dodecyl sulphate^polyacrylamide gel electrophoresis (SDS^PAGE) and transferred onto nitrocellulose. Blots were probed
with [32P]-labelled glutathione-S-transferase-ligand binding domain (GST-LBD) in the presence or absence of 10 nM 17L-oestradiol of hormone.
Prior to the preparation of nuclear extracts the ZR-75 cells were grown in 10% foetal calf serum (FCS) devoid of oestrogens (NH), 10 nM oes-
tradiol (E2), 10 nM 4-hydroxy tamoxifen (Tam), 10 nM pure anti-oestrogen ICI 182780 and retinoic acid (RA).
Fig. 2. Schematic organisation of RIP140 and RIP160. RIP140 comprises 1158 amino acids with nine perfect LXXLL motifs 1^9 and an
LXXLL-like motif 10 together with binding sites for HDACs and CtBP. RIP160 proteins comprise a family of proteins of approximately 1400
amino acids with three conserved LXXLL motifs M1^M3 and a fourth motif M4 present in certain isoforms. In addition there is a basic helix-
loop-helix region capable of interacting with BAF57, a binding site for CBP/p300, a glutamine-rich region Qn, implicated in binding androgen
receptors and a binding site for a protein methyltransferase.
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widely expressed but in speci¢c cell types at speci¢c stages of
development or hormonal control (Fig. 3). Mice devoid of
RIP140 are viable but smaller than their wild-type littermates,
partly due to a reduction in white adipose tissue. Strikingly,
female mice are completely infertile because there is a com-
plete failure of mature follicles to release oocytes at ovulation.
Whereas the pre-ovulatory surge of luteinising hormone (LH)
in normal mice normally induces both ovulation and luteini-
sation, in mice lacking RIP140 the oocytes are retained within
the follicle (Fig. 4), while luteinisation proceeds [12]. This
phenotype closely resembles that of luteinised unruptured fol-
licle syndrome often associated with infertility in women.
Therefore, the ability to suppress the action of nuclear recep-
tors is essential for the normal coordinated control of ovarian
function, with the process of oocyte release dependent on the
activity of RIP140.
Two approaches indicate that ovulatory failure is due to a
primary defect in the ovary itself. Firstly, oocyte release could
not be induced by standard exogenous hormone treatments
(pregnant mare’s serum (PMSG) and human chorionic gona-
dotropin (HCG)) designed to ‘superovulate’ mice [12]. This
indicates that the defect does not re£ect inadequacies in the
initial pituitary stimulation of follicle growth or the pre-ovu-
latory LH surge. Direct evidence that the defect lies at the
ovarian level rather than the hypothalamic^pituitary axis
comes from ovarian transplantation experiments [17]. Ovaries
Fig. 3. Tissue distribution of RIP140. The RIP140 coding sequence has been replaced by the lac Z gene so that L-galactosidase activity repre-
sents a marker of RIP140 promoter activity. Expression was detected in numerous tissues including the ovaries, uterus, testes, brain and pitui-
tary. It is noteworthy that the expression in the ovary is predominantly in mural granulosa cells with some expression in thecal cells while that
in the uterus is predominantly in the stromal compartment.
Fig. 4. RIP140 null mice exhibit an anovulatory phenotype. Ovarian
sections stained with hematoxylin and eosin demonstrate the pres-
ence of retained oocytes (indicated by arrows) in mice devoid of the
RIP140 gene.
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from 4-week-old immature RIP140 null mice were transferred
into wild-type or heterozygous littermates and vice versa.
Continuous breeding experiments indicated that the transfer
of ovaries from wild-type mice into RIP140 null mice rescued
their fertility whereas control mice with RIP140 null ovaries
generated very few pups, all of which were dead at birth or
died within 72 h. Thus we conclude that RIP140 expression in
the ovary is necessary for ovulation and that expression in
other tissues is not essential for this process to occur.
The precise site of RIP140 action in the ovary required for
ovulation has not been determined de¢nitively. As judged by
monitoring L-galactosidase activity, the highest levels of
RIP140 expression are found in granulosa cells but low levels
are also present in thecal and interstitial cells. No expression
was detected in the granulosa cells of primary follicles or
small follicles, but it became apparent during follicular mat-
uration, with the highest expression occurring in the outer
mural cells in pre-ovulatory follicles. Expression levels dra-
matically decreased after luteinisation but were subsequently
regulated in the corpora lutea of pregnant mice (see later).
RIP140 expression was also apparent in the uterus. In non-
pregnant females, expression occurred in the glandular epithe-
lium and stroma, and became apparent in primary decidual
cells around the time of implantation. By 9.5 days post-coitum
(p.c.), expression was primarily detected in di¡erentiating de-
cidual cells on the anti-mesometrial side of the uterus. The
role of RIP140 expression in the uterus was examined by
performing embryo transfer experiments (thereby bypassing
the initial ovulatory defect). The transfer of wild-type em-
bryos into pseudopregnant RIP140 null females resulted in a
similar number of implantation sites as for wild-type mice,
indicating that uterine RIP140 is not required for implanta-
tion. At later stages of pregnancy, however, there was a pro-
gressive reduction in the number of surviving embryos in the
RIP140 null mice suggesting that uterine RIP140 expression
might be required to maintain the pregnancy. In addition,
while the majority of pups born from control mothers sur-
vived after birth, 75% of the pups from RIP140 null mothers
were dead within 24 h.
The high incidence of foetal loss in mid-pregnancy and the
death of the majority of pups at or shortly after birth follow-
ing embryo transfer suggests that some aspects of the mater-
nal expression of RIP140 are suboptimal for the maintenance
of pregnancy and for the subsequent survival of o¡spring. The
embryo transfer experiments suggested that the uterine envi-
ronment and mammary gland function in RIP140 null mice is
suboptimal for the complete maintenance of a pregnancy and
subsequent suckling of pups. However, the ovarian transfer
experiments indicated that uterine and mammary gland
RIP140 expression is not essential for pregnancy and survival.
We conclude from this apparent disparity that the pregnancy
failure and the death of pups may re£ect a defect in the
RIP140 null ovary which fails to support fully the function
of the uterus and the mammary gland.
A continuing role of RIP140 in ovarian function during
pregnancy would be consistent with the expression of
RIP140 in the ovary during pregnancy. While there is negli-
gible expression at day 6.5 p.c., expression increases at mid-
gestation, is maintained until at least day 13.5 p.c. when em-
bryonic death is evident, and then declines to negligible levels
at day 17.5 p.c., correlating with initiation of the regression of
the corpora lutea. It is noteworthy that while the initial failure
of oocyte release did not a¡ect luteinisation and production of
progesterone in the early stages of pregnancy, the normal mid-
gestation rise in progesterone levels was not as pronounced in
embryo-transferred RIP140 null mice. This is despite the fact
that the corpora lutea were still large and apparently healthy.
Thus although RIP140 is widely expressed in the reproductive
tract, its primary role in female reproductive success appears
to re£ect its function in the ovary.
4. Concluding remarks
The ovulatory failure exhibited by RIP140 null mice resem-
bles that of mice devoid of progesterone receptors [13] and
cyclooxygenase 2 (COX-2; [14]), which raises the question as
to whether there is a functional interaction between RIP140
and these proteins. Both of these proteins are expressed in the
pre-ovulatory follicle following the LH surge: the progester-
one receptor is necessary for the expression of a number of
proteases involved in follicular disruption, while COX-2 is
required for the essential production of prostaglandin E2. It
was possible, therefore, that the anovulatory phenotype of
RIP140 null mice could be explained by disruption of the
normal expression of either the progesterone receptor or
COX-2. However this proved not to be the case and the ki-
netics of induction of the two genes in RIP140 null mice
precisely parallels that of wild-type mice. Expression pro¢ling
has now indicated a number of other genes whose expression
is altered in RIP140 null mice and we are now in the process
of determining their role in ovulation.
It is conceivable that RIP140 signalling might serve as a
target for contraceptive development since its deletion pre-
vents oocyte release but does not appear to adversely a¡ect
the other events associated with the normal ovarian cycle.
Therefore our future goals include the identi¢cation of the
crucial nuclear receptor(s) whose activity is blocked by
RIP140 in the ovary and the target genes for these nuclear
receptors essential for ovulation.
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